NCR Tables - Distribution By Histopathology Findings

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
B01AF01	XAVIRAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	952,208 L.L
B01AF01	RIXALTA 20	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,164,664 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
B01AF01	XARELTO	B	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,588,892 L.L
B01AF01	VAROXA	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	2,879,854 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	1,439,255 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	606,649 L.L
B01AF01	RIXALTA 10	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	671,921 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	959,888 L.L
B01AF02	ELIQUIS	B	Apixaban - 5mg	5mg	Tablet, film coated	4,183,603 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 5mg	5mg	Tablet	3,084,119 L.L
B01AF02	AVIXAN	G	Apixaban - 5mg	5mg	Tablet, film coated	2,777,275 L.L
B01AF02	ELIQUIS	B	Apixaban - 2.5mg	2.5mg	Tablet, film coated	4,183,603 L.L
B01AF02	APO-APIXABAN	G	Apixaban - 2.5mg	2.5mg	Tablet	3,084,119 L.L
B01AF02	AVIXAN	G	Apixaban - 2.5mg	2.5mg	Tablet, film coated	2,777,275 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 2.5mg/0.5ml	2.5mg/0.5ml	Injectable solution	5,341,774 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
B02AA02	EXACYL	B	Tranexamic acid - 500mg/5ml	500mg/5ml	Injectable solution	748,520 L.L
B02BA01	PHYTOMENADIONE (VITAMINE K1) PANPHARMA	G	Phytomenadione - 10mg/ml	10mg/ml	Solution	740,457 L.L
B02BA01	KONAKION MM PEDIATRIC	B	Phytomenadione - 2mg/0.2ml	2mg/0.2ml	Solution	442,124 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	37,803,732 L.L
B02BB01	FIBRYGA	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution+solvent	37,257,808 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	75,608,610 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	53,437,592 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	24,369,850 L.L
B02BC30-V03AK	TISSEEL LYO	B	Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml		Injectable powder for solution + solution	13,394,024 L.L
B02BD01	OCTAPLEX	BioHuman	Prothrombin complex, human (PPSB) - 500IU	500IU	Injectable powder for solution+diluent	35,672,956 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,270,499 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L

جداول بيانية لسجل الوطني للسرطان - توزيع الحالات حسب خصائص الانسجة